Page last updated: 2024-08-26

sr141716 and Hypertension

sr141716 has been researched along with Hypertension in 13 studies

Research

Studies (13)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	8 (61.54)	29.6817
2010's	5 (38.46)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Berghold, A; Horvath, K; Jeitler, K; Semlitsch, T; Siebenhofer, A; Siering, U	1
Berghold, A; Horvath, K; Jeitler, K; Meschik, J; Posch, N; Semlitsch, T; Siebenhofer, A	1
Berghold, A; Horvath, K; Jeitler, K; Matyas, E; Pignitter, N; Siebenhofer, A; Siering, U; Stich, AK	1
Cohen, SB; DiPetrillo, K; Xu, L; Zhang, Y	1
Madsbad, S	1
Balla, A; Catt, KJ; Hunyady, L; Nádasy, GL; Soltész-Katona, E; Szekeres, M; Tóth, ZE; Turu, G	1
Kaminski, NE; Li, J; Wang, DH	1
Bátkai, S; Bukoski, RD; Harvey-White, J; Kunos, G; Liu, J; Mackie, K; Offertáler, L; Osei-Hyiaman, D; Pacher, P; Radaeva, S; Rudd, MA	1
Henzen, C	1
Nilsson, PM	1
Bodary, PF; Eitzman, DT; Iglay, HB	1
Després, JP; Mancia, G; Pi-Sunyer, X; Ruilope, LM; Scheen, A; Van Gaal, L; Zanchetti, A	1
Arenare, F; Brambilla, G; Grassi, G; Mancia, G; Quarti-Trevano, F; Seravalle, G	1

Reviews

6 review(s) available for sr141716 and Hypertension

Article	Year
Long-term effects of weight-reducing drugs in hypertensive patients. The Cochrane database of systematic reviews, 2013, Mar-28, Issue:3 Topics: Adult; Anti-Obesity Agents; Blood Pressure; Cyclobutanes; Diet, Reducing; Female; Humans; Hypertension; Lactones; Male; Middle Aged; Orlistat; Piperidines; Pyrazoles; Randomized Controlled Trials as Topic; Rimonabant; Safety-Based Drug Withdrawals; Time; Weight Loss	2013
Long-term effects of weight-reducing drugs in people with hypertension. The Cochrane database of systematic reviews, 2016, Mar-02, Volume: 3 Topics: Adult; Anti-Obesity Agents; Appetite Depressants; Blood Pressure; Cyclobutanes; Diet, Reducing; Female; Fructose; Humans; Hypertension; Lactones; Male; Middle Aged; Orlistat; Phentermine; Piperidines; Pyrazoles; Randomized Controlled Trials as Topic; Rimonabant; Safety-Based Drug Withdrawals; Time; Topiramate; Weight Loss	2016
Long-term effects of weight-reducing drugs in hypertensive patients. The Cochrane database of systematic reviews, 2009, Jul-08, Issue:3 Topics: Adult; Anti-Obesity Agents; Blood Pressure; Cyclobutanes; Female; Humans; Hypertension; Lactones; Male; Middle Aged; Orlistat; Piperidines; Pyrazoles; Randomized Controlled Trials as Topic; Rimonabant; Time; Weight Loss	2009
[Internal medicine--update 2006]. Praxis, 2007, Mar-14, Volume: 96, Issue:11 Topics: Adrenal Gland Neoplasms; Bradykinin; Carotid Stenosis; Clinical Trials as Topic; Contrast Media; Endarterectomy, Carotid; Esophageal and Gastric Varices; Female; Heart Failure; Humans; Hyperglycemia; Hypertension; Hyperthyroidism; Internal Medicine; Male; Middle Aged; Osteitis Deformans; Piperidines; Pulmonary Disease, Chronic Obstructive; Pyrazoles; Renal Insufficiency; Rimonabant; Risk Factors; Stents; Stethoscopes; Weight Loss	2007
Strategies to reduce vascular risk associated with obesity. Current vascular pharmacology, 2007, Volume: 5, Issue:4 Topics: Adiponectin; Anti-Obesity Agents; Cardiovascular Diseases; Cyclobutanes; Diabetes Mellitus, Type 2; Humans; Hyperlipidemias; Hypertension; Lactones; Obesity; Orlistat; Piperidines; Pyrazoles; Rimonabant; Risk Factors	2007
Blood pressure lowering effects of rimonabant in obesity-related hypertension. Journal of neuroendocrinology, 2008, Volume: 20 Suppl 1 Topics: Animals; Antihypertensive Agents; Blood Pressure; Cannabinoids; Down-Regulation; Humans; Hypertension; Obesity; Piperidines; Pyrazoles; Rimonabant; Sympathetic Nervous System	2008

Trials

1 trial(s) available for sr141716 and Hypertension

Article	Year
Effect of rimonabant on blood pressure in overweight/obese patients with/without co-morbidities: analysis of pooled RIO study results. Journal of hypertension, 2008, Volume: 26, Issue:2 Topics: Adult; Blood Pressure; Cannabinoid Receptor Antagonists; Diabetes Mellitus, Type 2; Double-Blind Method; Dyslipidemias; Female; Humans; Hypertension; Male; Middle Aged; Obesity; Piperidines; Pyrazoles; Rimonabant; Weight Loss	2008

Article

Year

Effect of rimonabant on blood pressure in overweight/obese patients with/without co-morbidities: analysis of pooled RIO study results.

Journal of hypertension, 2008, Volume: 26, Issue:2

Topics: Adult; Blood Pressure; Cannabinoid Receptor Antagonists; Diabetes Mellitus, Type 2; Double-Blind Method; Dyslipidemias; Female; Humans; Hypertension; Male; Middle Aged; Obesity; Piperidines; Pyrazoles; Rimonabant; Weight Loss

2008

Other Studies

6 other study(ies) available for sr141716 and Hypertension

Article	Year
TrkB agonist antibody dose-dependently raises blood pressure in mice with diet-induced obesity. American journal of hypertension, 2010, Volume: 23, Issue:7 Topics: Animals; Anti-Obesity Agents; Antibodies, Monoclonal; Blood Pressure; Body Weight; Brain-Derived Neurotrophic Factor; Diet; Dietary Fats; Hypertension; Mice; Mice, Inbred C57BL; Obesity; Piperidines; Pyrazoles; Receptor, trkB; Rimonabant; Telemetry; Weight Loss	2010
[Long-term effects of weight-reducing drugs in hypertensive patients--a survey of a Cochrane review]. Ugeskrift for laeger, 2011, Feb-21, Volume: 173, Issue:8 Topics: Adult; Anti-Obesity Agents; Appetite Depressants; Blood Pressure; Cardiovascular Diseases; Cyclobutanes; Evidence-Based Medicine; Humans; Hypertension; Lactones; Obesity; Orlistat; Piperidines; Pyrazoles; Randomized Controlled Trials as Topic; Rimonabant; Time Factors; Treatment Outcome; Weight Loss	2011
Angiotensin II induces vascular endocannabinoid release, which attenuates its vasoconstrictor effect via CB1 cannabinoid receptors. The Journal of biological chemistry, 2012, Sep-07, Volume: 287, Issue:37 Topics: Analgesics; Angiotensin II; Animals; Arteries; Benzoxazines; Endocannabinoids; Endothelium, Vascular; Hypertension; Male; Mice; Mice, Knockout; Morpholines; Muscle, Skeletal; Naphthalenes; Piperidines; Pyrazoles; Rats; Rats, Wistar; Receptor, Cannabinoid, CB1; Rimonabant; Vasoconstriction	2012
Anandamide-induced depressor effect in spontaneously hypertensive rats: role of the vanilloid receptor. Hypertension (Dallas, Tex. : 1979), 2003, Volume: 41, Issue:3 Pt 2 Topics: Animals; Arachidonic Acids; Blood Pressure; Calcitonin Gene-Related Peptide; Capsaicin; Endocannabinoids; Hypertension; Male; Mesenteric Arteries; Piperidines; Polyunsaturated Alkamides; Pyrazoles; Rats; Rats, Inbred SHR; Rats, Inbred WKY; Receptors, Cannabinoid; Receptors, Drug; Rimonabant	2003
Endocannabinoids acting at cannabinoid-1 receptors regulate cardiovascular function in hypertension. Circulation, 2004, Oct-05, Volume: 110, Issue:14 Topics: Amidohydrolases; Angiotensin II; Animals; Arachidonic Acids; Benzamides; Benzyl Compounds; Blood Pressure; Camphanes; Carbamates; Dronabinol; Endocannabinoids; Endothelium, Vascular; Hypertension; Male; Models, Cardiovascular; Myocardial Contraction; Myocardium; Piperidines; Polyunsaturated Alkamides; Pyrazoles; Rats; Rats, Inbred Dahl; Rats, Inbred SHR; Rats, Inbred WKY; Rats, Sprague-Dawley; Receptor, Cannabinoid, CB1; Rimonabant; Up-Regulation; Vascular Resistance; Vasodilation; Ventricular Function, Left	2004
Blood pressure-lowering drugs not considered as antihypertensives. Current hypertension reports, 2007, Volume: 9, Issue:4 Topics: Antihypertensive Agents; Blood Pressure; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hypertension; Piperidines; Pyrazoles; Rimonabant; Thiazolidinediones	2007